Profile

Elizabeth Susan LyerlyWake Forest School of Medicine

Elizabeth Susan Lyerly

Instructor,

Contact Information

Academic: 336-716-4464 | Department: 336-716-4464

Email: slyerly@wakehealth.edu

Education & Training

  • B.A., Wake Forest University, 1980
  • P.A., Wake Forest Univ School of Medicine PA Program, 1982

Memberships

  • Am Academy Of Physician Assist
  • Piedmont Assn Of Physician Ass

NPI Number

  • 1245448737
Elizabeth Susan Lyerly

Elizabeth Susan Lyerly

Instructor, Hematology & Oncology

Contact Information

Academic: 336-716-4464 | Department: 336-716-4464

Email: slyerly@wakehealth.edu

Recent Publications

A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies. Pardee TS, Lee K, Luddy J, Maturo C, Rodriguez R, Isom S, Miller LD, Stadelman KM, Levitan D, Hurd D, Ellis LR, Harrelson R, Manuel M, Dralle S, Lyerly S, Powell BL.. Clin Cancer Res. 2014;20(20):5255-5264.

The mitochondrial metabolism inhibitor Cpi-613 is highly active in combination with high dose Ara-C (HiDAC) and mitoxantrone in a phase I study for relapsed or refractory acute myeloid leukemia (AML). Pardee TS, Stadelman K, Isom S, Ellis LR, Berenzon D, Hurd DD, Harrelson R, Manuel M, Dralle S, Lyerly S [sic] [Lyerly ES], Powell BL.. Blood. 2014;124(21):3744.

A single institution analysis of incidence of recurrent chromosomal abnormalities in adult ALL patients according to race, gender, and age [abstract]. Chiou V, Tiegs J, Isom S, Pettenati MJ, Lyerly S, Ellis LR, Pardee T, Dmitriy B, Powell BL, Levitan DA.. Blood. 2011;118(21):4869.

High dose cytarabine and clofarabine (HiDAC-->CLOF) in relapsed or refractory acute myeloid leukemia, a phase 2 trial [abstract]. Powell B, D'Agostino R Jr, Levitan D, Ellis LR, Lyerly S, Skiles M, Manuel M, Harrelson R, Kimbrough C, Hurd DD.. Blood. 2008;112(11):676.

Limited phase I trial of sequential high dose cytarabine and clofarabine (HiDAC-->CLOF) in relasped or refractory acute myeloid leukemia [abstract]. Powell BL, Lovato J, Kimbrough C, Lyerly S, Galloway-Daniels S, Harrelson R, Keung YK, Thakuri MC, Molnar I, Levitan D, Hurd DD, et al.. Blood. 2006;108(11 Pt 2):221b.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Instructor, Hematology & Oncology

Elizabeth Susan Lyerly

Elizabeth Susan Lyerly

Instructor, Hematology & Oncology

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.